A call to action to bring stakeholders together to plan for the future of LLM-enhanced cancer survivorship.
No takes yet. Share an insight, caveat, or question.
Bitterman et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: